Literature DB >> 18280757

Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis.

P S Emrani1, J N Katz, C L Kessler, W M Reichmann, E A Wright, T E McAlindon, E Losina.   

Abstract

OBJECTIVE: While the interpretation of cartilage findings on magnetic resonance imaging (MRI) evolves, plain radiography remains the standard method for assessing progression of knee osteoarthritis (OA). We sought to describe factors that explain variability in published estimates of radiographic progression in knee OA.
DESIGN: We searched PubMed between January 1985 and October 2006 to identify studies that assessed radiographic progression using either joint space narrowing (JSN) or the Kellgren-Lawrence (K-L) scale. We extracted cohort characteristics [age, gender, and body mass index (BMI)] and technical and other study factors (radiographic approach, study design, OA-related cohort composition). We performed meta-regression analyses of the effects of these variables on both JSN and K-L progression.
RESULTS: Of 239 manuscripts identified, 34 met inclusion criteria. The mean estimated annual JSN rate was 0.13 +/- 0.15 mm/year. While we found no significant association between JSN and radiographic approach among observational studies, full extension was associated with greater estimated JSN among randomized control trials (RCTs). Overall, observational studies that used the semi-flexed approach reported greater JSN than RCTs that used the same approach. The overall mean risk of K-L progression by at least one grade was 5.6 +/- 4.9%, with higher risk associated with shorter study duration, OA definition (K-L > or = 2 vs K-L > or = 1) and cohorts composed of subjects with both incident and prevalent OA.
CONCLUSION: While radiographic approach and study design were associated with JSN, OA definition, cohort composition and study duration were associated with risk of K-L progression. These findings may inform the design of disease modifying osteoarthritis drug (DMOAD) trials and assist clinicians in optimal timing of OA treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18280757      PMCID: PMC2701468          DOI: 10.1016/j.joca.2007.12.004

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  50 in total

1.  Radiographic progression of knee osteoarthritis in a Czech cohort.

Authors:  K Pavelka; J Gatterova; R D Altman
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

2.  The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis.

Authors:  Frederick Wolfe; Nancy E Lane
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

Review 3.  Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis?

Authors:  Kenneth D Brandt; Steven A Mazzuca; Thierry Conrozier; Jane E Dacre; Charles G Peterfy; Diego Provvedini; Phillipe Ravaud; Alain Taccoen; Eric Vignon
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

4.  Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis.

Authors:  T Miyazaki; M Wada; H Kawahara; M Sato; H Baba; S Shimada
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

5.  The role of knee alignment in disease progression and functional decline in knee osteoarthritis.

Authors:  L Sharma; J Song; D T Felson; S Cahue; E Shamiyeh; D D Dunlop
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

6.  Comparison of fixed flexion, fluoroscopic semi-flexed and MTP radiographic methods for obtaining the minimum medial joint space width of the knee in longitudinal osteoarthritis trials.

Authors:  G A Cline; J M Meyer; R Stevens; C Buckland-Wright; C Peterfy; John F Beary
Journal:  Osteoarthritis Cartilage       Date:  2006-05-08       Impact factor: 6.576

7.  The validity of different definitions of radiographic worsening for longitudinal studies of knee osteoarthritis.

Authors:  M P LaValley; T E McAlindon; C E Chaisson; D Levy; D T Felson
Journal:  J Clin Epidemiol       Date:  2001-01       Impact factor: 6.437

8.  Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study.

Authors:  M Reijman; H A P Pols; A P Bergink; J M W Hazes; J N Belo; A M Lievense; S M A Bierma-Zeinstra
Journal:  Ann Rheum Dis       Date:  2006-07-12       Impact factor: 19.103

9.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

10.  Risk factors for the incidence and progression of radiographic knee osteoarthritis.

Authors:  C Cooper; S Snow; T E McAlindon; S Kellingray; B Stuart; D Coggon; P A Dieppe
Journal:  Arthritis Rheum       Date:  2000-05
View more
  54 in total

1.  Progression analysis and stage discovery in continuous physiological processes using image computing.

Authors:  Lior Shamir; Salim Rahimi; Nikita Orlov; Luigi Ferrucci; Ilya G Goldberg
Journal:  EURASIP J Bioinform Syst Biol       Date:  2010-06-30

Review 2.  Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis.

Authors:  Mark D Kohn; Adam A Sassoon; Navin D Fernando
Journal:  Clin Orthop Relat Res       Date:  2016-02-12       Impact factor: 4.176

3.  The incident tibiofemoral osteoarthritis with rapid progression phenotype: development and validation of a prognostic prediction rule.

Authors:  D L Riddle; P W Stratford; R A Perera
Journal:  Osteoarthritis Cartilage       Date:  2016-07-05       Impact factor: 6.576

4.  TIM-3 Genetic Variations Affect Susceptibility to Osteoarthritis by Interfering with Interferon Gamma in CD4+ T Cells.

Authors:  Shufeng Li; Yanjun Ren; Dayong Peng; Zhen Yuan; Shiying Shan; Huaqiang Sun; Xinfeng Yan; Hong Xiao; Guang Li; Haihan Song
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

5.  Baseline trabecular bone and its relation to incident radiographic knee osteoarthritis and increase in joint space narrowing score: directional fractal signature analysis in the MOST study.

Authors:  P Podsiadlo; M C Nevitt; M Wolski; G W Stachowiak; J A Lynch; I Tolstykh; D T Felson; N A Segal; C E Lewis; M Englund
Journal:  Osteoarthritis Cartilage       Date:  2016-05-07       Impact factor: 6.576

6.  MRI and biomechanics multidimensional data analysis reveals R2 -R as an early predictor of cartilage lesion progression in knee osteoarthritis.

Authors:  Valentina Pedoia; Jenny Haefeli; Kazuhito Morioka; Hsiang-Ling Teng; Lorenzo Nardo; Richard B Souza; Adam R Ferguson; Sharmila Majumdar
Journal:  J Magn Reson Imaging       Date:  2017-05-04       Impact factor: 4.813

7.  Progression of medial compartmental osteoarthritis 2-8 years after lateral closing-wedge high tibial osteotomy.

Authors:  M R Huizinga; J Gorter; A Demmer; S M A Bierma-Zeinstra; R W Brouwer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-07-07       Impact factor: 4.342

8.  A quantitative metric for knee osteoarthritis: reference values of joint space loss.

Authors:  C Ratzlaff; E L Ashbeck; A Guermazi; F W Roemer; J Duryea; C K Kwoh
Journal:  Osteoarthritis Cartilage       Date:  2018-05-26       Impact factor: 6.576

9.  Moving to maintain function in knee osteoarthritis: evidence from the osteoarthritis initiative.

Authors:  Dorothy D Dunlop; Pamela Semanik; Jing Song; Leena Sharma; Michael Nevitt; Rebecca Jackson; Jerry Mysiw; Rowland W Chang
Journal:  Arch Phys Med Rehabil       Date:  2010-05       Impact factor: 3.966

10.  Mobilization with movement and kinesio taping in knee arthritis-evaluation and outcomes.

Authors:  Hülya Altmış; Deran Oskay; Bülent Elbasan; İrem Düzgün; Zeynep Tuna
Journal:  Int Orthop       Date:  2018-05-10       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.